Nanosonics

Nanosonics Net Margin

The Net Profit Margin of Nanosonics (NAN.AX) as of Oct 31, 2026 is 8.77 %. In the previous year, Net Profit Margin was 10.39 % — a change of -15.66% (lower).

Net Margin

8.77 %

YoY

-15.66%

Last updated:

Net Profit Margin of Nanosonics is 2026 8.77 % . Net Profit Margin of Nanosonics was 2025 10.39 % . It decreases by -15.66% lower compared to the previous year.

Nanosonics's net margin stands at 8.8%, up from 3.1% several years earlier.

The Nanosonics Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
16.13 AUD
Jan 1, 2020
10.20 AUD
Jan 1, 2021
8.42 AUD
Jan 1, 2022
3.13 AUD
Jan 1, 2023
11.87 AUD
Jan 1, 2024
7.56 AUD
Jan 1, 2025
10.39 AUD
Jan 1, 2026
8.77 AUD
The Nanosonics Net Margin history
YEARNet MarginYoY
8.77 %-15.66%
10.39 %+37.46%
7.56 %-36.30%
11.87 %+279.77%
3.13 %-62.90%
8.42 %-17.42%
10.20 %-36.77%
16.13 %+70.25%
9.47 %-75.55%
38.75 %+13,492.49%
0.29 %-101.16%
-24.58 %+102.78%
-12.12 %+3,030.85%
-0.39 %+1.78%
-0.38 %-92.38%
-4.99 %-53.40%
-10.71 %-62.19%
-28.33 %+340.79%
-6.43 %-99.05%
-677.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Nanosonics Stock analysis

What does Nanosonics do? Nanosonics Ltd is an Australian company specializing in the development of innovative disinfectants designed specifically for use in medical facilities. The company was founded in 2000 by two scientists, Ron Weinberger and Kelvin Trautman, with the aim of reducing the spread of infections through medical devices and equipment. Nanosonics developed a new disinfectant based on the use of ultrasound to achieve higher effectiveness. Its first product, the Trophon EPR, was launched in 2007 and was the world's first Dry Chemical Disinfection system specifically designed for ultrasound probes. Nanosonics has since expanded its product line to include the Trophon2, an improved version of the Trophon EPR, and Ultra, a hand sanitizer for use in medical facilities. It has also developed the TRISTEL Duo disinfection system for flexible endoscopes. Nanosonics is focused on sustainable growth and works closely with customers to develop products tailored to their specific needs. The company is headquartered in Sydney, Australia, with branches in Europe and North America to support global expansion. Technological innovation and collaboration with customers have helped Nanosonics establish itself as a leading provider of disinfection solutions for medical facilities, ensuring patient safety and infection control. Nanosonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanosonics stock

Net Profit Margin of Nanosonics is 8.77 % in 2026.

Net Profit Margin of Nanosonics changed from 10.39 % to 8.77 %, representing a -15.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Nanosonics since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Nanosonics with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Nanosonics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Nanosonics